NEU 1.49% $19.87 neuren pharmaceuticals limited

Researchers say inflammation is key TBI culprit, page-26

  1. 1,795 Posts.
    lightbulb Created with Sketch. 417
    Great post Hottod. One question...in 2013, Investor presentation of NEU said that only one late stage completion for TBI was from Progestone...no other competitors get a mention , yet so many listed on your post? Why do you think there is this anomaly?
    Thanks
    boc
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.